DEPAU LORENZO | Professor page

Depau, L., Brunetti, J., Falciani, C., Mandarini, E., Zanchi, M., Paolocci, M.F., et al. (2025). Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 12 [10.3389/fcell.2024.1505680]. - view more
Andreano, E., Nicastri, E., Paciello, I., Pileri, P., Manganaro, N., Piccini, G., et al. (2021). Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. CELL, 184(7), 1821-1835.e16 [10.1016/j.cell.2021.02.035]. - view more
Mandarini, E., Tollapi, E., Zanchi, M., Depau, L., Pini, A., Brunetti, J., et al. (2020). Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 21(21), 1-13 [10.3390/ijms21218282]. - view more
Brunetti, J., Piantini, S., Fragai, M., Scali, S., Cipriani, G., Depau, L., et al. (2020). A new NT4 peptide-based drug delivery system for cancer treatment. MOLECULES, 25(5) [10.3390/molecules25051088]. - view more
Depau, L., Brunetti, J., Falciani, C., Mandarini, E., Riolo, G., Zanchi, M., et al. (2020). Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells. JOURNAL OF MEDICINAL CHEMISTRY, 63(24), 15997-16011 [10.1021/acs.jmedchem.0c01848]. - view more